Literature DB >> 12145407

Multiple actions of pituitary adenylyl cyclase activating peptide in nervous system development and regeneration.

James A Waschek1.   

Abstract

Pituitary adenylyl cyclase activating peptide (PACAP) is widely expressed in the embryonic brain at the onset of neurogenesis, and is strongly upregulated in several models of nerve injury. Moreover, high-affinity PACAP receptors are expressed in proliferative zones in the embryonic and postnatal nervous system suggesting that PACAP regulates the development of both neuronal and glial precursors. Tissue culture studies indicate that PACAP exerts a variety of growth factor-like actions that depend on the origin of the cell population and developmental stage. These effects include regulation of proliferation, survival, maturation, neurite outgrowth, and expression of trophic factors, cytokines and trk receptors. The presence of other growth factors can also markedly affect these actions of PACAP, for example, reversing PACAP's effect from proliferative to antiproliferative. In vivo models now provide additional evidence that PACAP acts in neural development and regeneration. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12145407     DOI: 10.1159/000064942

Source DB:  PubMed          Journal:  Dev Neurosci        ISSN: 0378-5866            Impact factor:   2.984


  69 in total

Review 1.  You can't go home again: transcriptionally driven alteration of cell signaling by NGF.

Authors:  Lloyd A Greene; James M Angelastro
Journal:  Neurochem Res       Date:  2005-10       Impact factor: 3.996

2.  Degree of damage compensation by various PACAP treatments in monosodium glutamate-induced retinal degeneration.

Authors:  Norbert Babai; Tamás Atlasz; Andrea Tamás; Dóra Reglödi; Gábor Tóth; Péter Kiss; Róbert Gábriel
Journal:  Neurotox Res       Date:  2005-11       Impact factor: 3.911

3.  Impaired nerve regeneration and enhanced neuroinflammatory response in mice lacking pituitary adenylyl cyclase activating peptide.

Authors:  B D Armstrong; C Abad; S Chhith; G Cheung-Lau; O E Hajji; H Nobuta; J A Waschek
Journal:  Neuroscience       Date:  2007-10-30       Impact factor: 3.590

4.  RANTES release contributes to the protective action of PACAP38 against sodium nitroprusside in cortical neurons.

Authors:  Alma Sanchez; Debjani Tripathy; Paula Grammas
Journal:  Neuropeptides       Date:  2009-06-03       Impact factor: 3.286

5.  Changes in the expression of PACAP-like compounds during the embryonic development of the earthworm Eisenia fetida.

Authors:  Akos Boros; Dora Reglodi; Zsofia Herbert; Gabor Kiszler; Jozsef Nemeth; Andrea Lubics; Peter Kiss; Andrea Tamas; Seiji Shioda; Kouhei Matsuda; Edit Pollak; Laszló Molnar
Journal:  J Mol Neurosci       Date:  2008-07-08       Impact factor: 3.444

6.  Reelin signals through apolipoprotein E receptor 2 and Cdc42 to increase growth cone motility and filopodia formation.

Authors:  Jost Leemhuis; Elisabeth Bouché; Michael Frotscher; Frank Henle; Lutz Hein; Joachim Herz; Dieter K Meyer; Marina Pichler; Günter Roth; Carsten Schwan; Hans H Bock
Journal:  J Neurosci       Date:  2010-11-03       Impact factor: 6.167

7.  Epac activation converts cAMP from a proliferative into a differentiation signal in PC12 cells.

Authors:  Simone Kiermayer; Ricardo M Biondi; Jochen Imig; Guido Plotz; Jörg Haupenthal; Stefan Zeuzem; Albrecht Piiper
Journal:  Mol Biol Cell       Date:  2005-10-05       Impact factor: 4.138

8.  Influence of terminal differentiation and PACAP on the cytokine, chemokine, and growth factor secretion of mammary epithelial cells.

Authors:  Katalin Csanaky; Wolfgang Doppler; Andrea Tamas; Krisztina Kovacs; Gabor Toth; Dora Reglodi
Journal:  J Mol Neurosci       Date:  2013-12-10       Impact factor: 3.444

9.  Src-dependent TrkA transactivation is required for pituitary adenylate cyclase-activating polypeptide 38-mediated Rit activation and neuronal differentiation.

Authors:  Geng-Xian Shi; Ling Jin; Douglas A Andres
Journal:  Mol Biol Cell       Date:  2010-03-10       Impact factor: 4.138

Review 10.  Novel neuroprotective strategies in ischemic retinal lesions.

Authors:  Krisztina Szabadfi; Laszlo Mester; Dora Reglodi; Peter Kiss; Norbert Babai; Boglarka Racz; Krisztina Kovacs; Aliz Szabo; Andrea Tamas; Robert Gabriel; Tamas Atlasz
Journal:  Int J Mol Sci       Date:  2010-02-03       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.